pharma · Anemia · Anemia Associated With Chronic Kidney Disease · AKBA
Akebia Europe
Akebia Europe Limited
Akebia Europe clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2007
- Employees
- 271
- Programs
- 25
- Drugs
- 13
- Patents
- 28
Akebia Europe projects
11 ClinicalTrials.gov programs sponsored by Akebia Europe.
Akebia Europe has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AKB-6548
Akebia Europe Limited
Healthy Volunteers
1 trial -
AKB-6548 (therapeutic dose)
Akebia Europe Limited
Healthy Volunteers
1 trial -
AKB-6548-CI-0013
Akebia Europe Limited
Healthy
1 trial -
AKB-9090
Akebia Europe Limited
Healthy Volunteers
1 trial -
Celecoxib
Akebia Europe Limited
Healthy Volunteers
1 trial -
Vadadustat
Akebia Europe Limited
Anemia Associated With Chronic Kidney Disease
1 trial -
Vadadustat
Akebia Europe Limited
Drug Interaction Potentiation
4 trials -
Vadadustat
Akebia Europe Limited
Healthy Volunteers
1 trial -
Vadadustat
Akebia Europe Limited
Hepatic Impairment
1 trial -
vadadustat
Akebia Europe Limited
Healthy
1 trial -
vadadustat reference tablets
Akebia Europe Limited
Healthy
1 trial
Frequently asked questions
How many clinical projects does Akebia Europe have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.